chr10:80979372-81035610 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979372-81035610 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979372-81035610 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024210-81056715 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80910867-81050402 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80910867-81050402 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80853343-80898226 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853343-80898226 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80997055-81054608 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80896793-80920816 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896793-80920816 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896793-80920816 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896793-80920816 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896793-80920816 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80888807-80955793 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80904252-80923434 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904252-80923434 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904252-80923434 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904252-80923434 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904252-80923434 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904252-80923434 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81000246-81036857 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904486-80923305 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80933547-80946338 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80888273-80921559 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888273-80921559 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888273-80921559 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888273-80921559 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888273-80921559 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80934612-80956871 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80885440-80918549 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80982423-81003050 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80982423-81003050 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80882830-80918184 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81004855-81035103 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81023362-81056236 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80982067-81010625 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80982067-81010625 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80897128-80919388 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897128-80919388 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896675-80919366 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896675-80919366 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894773-80923676 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80978254-81037003 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978254-81037003 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978254-81037003 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80838484-80846237 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80838484-80846237 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80838484-80846237 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80838484-80846237 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80869747-80879147 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80895593-80920483 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895593-80920483 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895593-80920483 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895593-80920483 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895593-80920483 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80998564-81054381 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80979883-81053665 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979883-81053665 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979883-81053665 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80896786-80957347 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80884256-80956335 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80884256-80956335 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80969425-81010961 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80969425-81010961 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80933565-80955501 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:81024626-81055655 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024626-81055655 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001125-81036107 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001325-81054393 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80978615-81053129 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978615-81053129 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80978615-81053129 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853257-80908940 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80888735-80920499 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888735-80920499 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888735-80920499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888735-80920499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888735-80920499 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81018783-81043018 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80968501-81004366 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80968501-81004366 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80859757-80964624 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80977581-81003094 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80977581-81003094 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81024172-81060320 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80903991-80920562 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80903991-80920562 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80903991-80920562 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80903991-80920562 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80903991-80920562 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908032-80918095 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830006-80920633 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80907547-80923601 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80907547-80923601 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80907547-80923601 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80907547-80923601 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80907547-80923601 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80907547-80923601 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80904644-80949499 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:81001997-81047825 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001997-81047825 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871575-80911911 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:81075076-81087263 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81075076-81087263 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996350-81059402 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80979539-81004453 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979539-81004453 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979234-81004968 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979234-81004968 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80895802-80921054 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895802-80921054 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895802-80921054 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895802-80921054 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895802-80921054 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830318-80875386 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80906677-80920352 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80906677-80920352 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80906677-80920352 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80906677-80920352 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80915888-80921107 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80915888-80921107 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80915888-80921107 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80915888-80921107 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80915888-80921107 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80937420-80945093 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80905642-80923546 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80905642-80923546 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80905642-80923546 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80905642-80923546 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905642-80923546 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905642-80923546 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80872064-80920593 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80889255-80920410 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80889255-80920410 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80889255-80920410 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80889255-80920410 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80889255-80920410 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895202-80921098 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895202-80921098 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895202-80921098 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895202-80921098 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895202-80921098 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80978452-81054262 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978452-81054262 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80978452-81054262 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80894886-80921269 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80894886-80921269 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80894886-80921269 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80894886-80921269 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894886-80921269 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80979218-81071695 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979218-81071695 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80979218-81071695 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80895186-80957160 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80980816-81071487 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80980816-81071487 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80980816-81071487 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80979415-81071591 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979415-81071591 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80979415-81071591 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80977110-81071906 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80977110-81071906 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80977110-81071906 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81001085-81059169 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80978705-81060415 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978705-81060415 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80978705-81060415 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80896412-80955823 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979036-81060255 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979036-81060255 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80979036-81060255 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80980788-81060074 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80980788-81060074 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80980788-81060074 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80896957-80921320 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896957-80921320 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896957-80921320 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896957-80921320 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896957-80921320 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80888809-80955671 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80997070-81078387 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80997070-81078387 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:80978247-81047312 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978247-81047312 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978247-81047312 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80896069-80956094 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80980818-81010854 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80980818-81010854 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81023984-81060204 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80888585-80963740 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80998800-81078422 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80998800-81078422 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81023740-81082905 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:80996106-81027431 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996106-81027431 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871599-80921158 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80871102-80948461 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80871581-80922714 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871581-80922714 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80897585-80920032 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897585-80920032 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897585-80920032 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897585-80920032 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80937823-80950490 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80908577-80922854 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908577-80922854 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908577-80922854 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908577-80922854 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908577-80922854 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908577-80922854 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80915955-80921500 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80915955-80921500 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80915955-80921500 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80915955-80921500 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80915955-80921500 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80907695-80918854 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80907695-80918854 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886367-80920739 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886367-80920739 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886367-80920739 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80886367-80920739 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886367-80920739 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80849516-80908426 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80894847-80921444 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80894847-80921444 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80894847-80921444 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80894847-80921444 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894847-80921444 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80932673-80950398 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979526-80986650 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80852976-80866525 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81003421-81012866 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870340-80880077 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828876-80835906 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80978221-81056202 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978221-81056202 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80978221-81056202 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80893912-80928620 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828920-80859179 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80928986-80953459 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80928986-80953459 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80861287-80910229 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861287-80910229 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861582-80919421 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827914-80920039 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80978299-81004544 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978299-81004544 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80851151-80857516 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80855138-80896546 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80855138-80896546 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80980265-81002908 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80980265-81002908 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80873576-80896402 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80962044-80991391 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80962044-80991391 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80962044-80991391 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80962044-80991391 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80962044-80991391 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80996627-81026253 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996627-81026253 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80995819-81035844 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80902818-80966847 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:81023960-81059547 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81023960-81059547 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861812-80905487 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80843647-80910524 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80861508-80910410 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861508-80910410 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80910609-80919885 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80910609-80919885 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80910609-80919885 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80910609-80919885 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888608-80919884 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888608-80919884 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888608-80919884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888608-80919884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80909707-80926477 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80904553-80919406 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904553-80919406 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80933669-80955540 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80830119-80889837 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830119-80889837 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80908188-80919866 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908188-80919866 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908188-80919866 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908188-80919866 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80979421-81041570 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979421-81041570 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979421-81041570 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80888147-80920772 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888147-80920772 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888147-80920772 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888147-80920772 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888147-80920772 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80935157-80964767 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979760-81036330 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979760-81036330 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979760-81036330 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80935559-80964750 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979815-81007417 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979815-81007417 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80884089-80921858 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80884089-80921858 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80884089-80921858 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80884089-80921858 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884089-80921858 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996932-81058711 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80896865-80920524 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896865-80920524 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896865-80920524 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896865-80920524 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896865-80920524 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80898317-80920431 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80898317-80920431 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80898317-80920431 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80898317-80920431 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80898317-80920431 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896903-80920500 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896903-80920500 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896903-80920500 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896903-80920500 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896903-80920500 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80897645-80920335 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897645-80920335 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897645-80920335 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897645-80920335 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80988059-81036462 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80875735-80921274 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81024426-81060804 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80996632-81059699 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81022842-81056680 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80870142-80924214 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80897166-80920352 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897166-80920352 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897166-80920352 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897166-80920352 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80869943-80921604 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870040-80920053 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870522-80920134 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81003311-81047538 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81001825-81026886 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001825-81026886 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001451-81047839 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81024180-81056253 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81045286-81056258 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81045286-81056258 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80898171-80919616 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80898171-80919616 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80898171-80919616 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80898171-80919616 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80872083-80919478 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886574-80919239 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886574-80919239 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886311-80919748 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886311-80919748 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886311-80919748 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80886311-80919748 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80901437-80919889 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80901437-80919889 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80901437-80919889 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80901437-80919889 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80872479-80888430 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861532-80919881 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870336-80919881 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870774-80920439 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895585-80923554 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828720-80877206 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81075030-81095868 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81075030-81095868 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:81075030-81095868 |
chr10:81094290 |
rs11002932 |
NA |
Elbow pain |
NA |
8.17e-05 |
GWASdb |
| chr10:81075030-81095868 |
chr10:81094702 |
rs16937080 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000403 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80870269-80957531 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:81076131-81098697 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81076131-81098697 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:81076131-81098697 |
chr10:81094290 |
rs11002932 |
NA |
Elbow pain |
NA |
8.17e-05 |
GWASdb |
| chr10:81076131-81098697 |
chr10:81094702 |
rs16937080 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000403 |
GWASdb |
| chr10:80908517-80919444 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908517-80919444 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908517-80919444 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908517-80919444 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828685-80862717 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80929556-80953215 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80929556-80953215 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80850844-80876648 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80850844-80876648 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80870939-80952893 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80870939-80952893 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80872509-80946036 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80872509-80946036 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:81019643-81035902 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81019643-81035902 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81019643-81035902 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81019643-81035902 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81019643-81035902 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80995046-81073028 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80905907-80973022 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80833076-80885446 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80833076-80885446 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80910966-80918988 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80910966-80918988 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80979618-81035660 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979618-81035660 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979618-81035660 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80895387-80920102 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895387-80920102 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895387-80920102 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895387-80920102 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80853130-80910591 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80908307-80919145 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908307-80919145 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897405-80919821 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897405-80919821 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897405-80919821 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897405-80919821 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80899159-80919714 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80899159-80919714 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80899159-80919714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80899159-80919714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830669-80842625 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830669-80842625 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830669-80842625 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81003695-81050344 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80997196-81055806 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80830280-80917426 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80886447-80955415 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80886447-80955415 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80886763-80923476 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886763-80923476 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80886763-80923476 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80886763-80923476 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886763-80923476 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80886763-80923476 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80979298-81047282 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979298-81047282 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979298-81047282 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80861068-81036328 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80861068-81036328 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80882362-80924202 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80882362-80924202 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81001114-81056482 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80859438-80947194 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80894911-80946098 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80894911-80946098 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80861372-80953447 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80861372-80953447 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80861219-80921763 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861219-80921763 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80861170-80963923 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80870865-80922855 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870865-80922855 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:81075508-81097680 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:81075508-81097680 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:81075508-81097680 |
chr10:81094290 |
rs11002932 |
NA |
Elbow pain |
NA |
8.17e-05 |
GWASdb |
| chr10:81075508-81097680 |
chr10:81094702 |
rs16937080 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000403 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871102-80923552 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80897287-80919617 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897287-80919617 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897287-80919617 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897287-80919617 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80897551-80919666 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80897551-80919666 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80897551-80919666 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80897551-80919666 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80870592-80955604 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80998443-81035866 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80998443-81035866 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80954225-80983737 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80968769-81006928 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80968769-81006928 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80907826-80920353 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80907826-80920353 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80907826-80920353 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80907826-80920353 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888358-80946657 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80871615-80946305 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80871615-80946305 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80828788-80854636 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828788-80854636 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81003030-81027528 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81003030-81027528 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80828399-80955725 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80828399-80955725 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80906985-80923714 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80906985-80923714 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80906985-80923714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80906985-80923714 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80906985-80923714 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80906985-80923714 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853273-80890055 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80860171-81042887 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80860171-81042887 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979395-81047436 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979395-81047436 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979395-81047436 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80888683-80965636 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80870496-80921347 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870496-80921347 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80910375-80964707 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979359-81043014 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979359-81043014 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979359-81043014 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80934259-80965705 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80978201-81047188 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978201-81047188 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978201-81047188 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80870052-80923215 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80861318-81047390 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80861318-81047390 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80935386-80964828 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80935386-80964828 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979229-81031718 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979229-81031718 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979229-81031718 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979229-81031718 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80888760-80965499 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979540-81047433 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979540-81047433 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979540-81047433 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80828858-81047998 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80828858-81047998 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80828858-81047998 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80979246-81047098 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979246-81047098 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979246-81047098 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979220-81035341 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979220-81035341 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979220-81035341 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80934785-80964927 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80978437-81079096 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80978437-81079096 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80978437-81079096 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80860764-81036295 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80860764-81036295 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979239-81048959 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979239-81048959 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80979239-81048959 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80873204-80920587 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:81001331-81028198 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001331-81028198 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81000967-81028205 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81000967-81028205 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80871667-80957688 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80860691-80955415 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80860691-80955415 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80979724-81003130 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979724-81003130 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80996931-81054517 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80872565-80911944 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80962182-81046209 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80962182-81046209 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80962182-81046209 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80962182-81046209 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80962182-81046209 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80962182-81046209 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80848669-80946478 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80848669-80946478 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80979670-81046897 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80979670-81046897 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80979670-81046897 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80895464-80920939 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895464-80920939 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895464-80920939 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895464-80920939 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80895464-80920939 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80934776-81047235 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80934776-81047235 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80861490-80920668 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861490-80920668 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80982504-81059133 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80982504-81059133 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80982504-81059133 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80997350-81060283 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80828468-80950289 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80828468-80950289 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81005631-81062329 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:81005631-81062329 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80829926-80955260 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80829926-80955260 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81000844-81027736 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81000844-81027736 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828696-80867033 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80827571-80854738 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80827571-80854738 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80853128-80911703 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80853128-80911703 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80853096-80911661 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80853096-80911661 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:81001434-81056238 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:81001434-81056238 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80903336-80923437 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80828867-80888121 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80903882-80950234 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80903882-80950234 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80904007-80918515 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80853265-80911581 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830245-80920764 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80828967-80927481 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80828967-80927481 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80830214-80927349 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80830214-80927349 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80860152-80920836 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80861018-80920746 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80861018-80920746 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80859623-80919361 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80882441-80920439 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80882441-80920439 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80882441-80920439 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80882441-80920439 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80882441-80920439 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80892420-80920471 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80892420-80920471 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80892420-80920471 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80892420-80920471 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80892420-80920471 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80829001-80964563 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80829001-80964563 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80861159-80920277 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80861159-80920277 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860684-80898545 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860152-80920836 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80933935-80964583 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80860916-80964399 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80860916-80964399 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80993244-81029722 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80993244-81029722 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80905918-80922177 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827659-80920520 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80986633-81050563 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80986633-81050563 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80987994-81050552 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80886781-80919206 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80886781-80919206 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896791-80920555 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80896791-80920555 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80896791-80920555 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80896791-80920555 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80896791-80920555 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80910035-80919408 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80910035-80919408 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908958-80919540 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908958-80919540 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908958-80919540 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908958-80919540 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80871852-80920935 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80937726-80955189 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80895577-80920176 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80895577-80920176 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80895577-80920176 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80895577-80920176 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80884741-80954434 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80830613-80862057 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80830613-80862057 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80908612-80952221 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80908612-80952221 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80908640-80950261 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80908640-80950261 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80909303-80924038 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80909303-80924038 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80937166-80949990 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80907661-80920587 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80907661-80920587 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80907661-80920587 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80907661-80920587 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80907661-80920587 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80904267-80950537 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80904573-80923950 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80904573-80923950 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80904531-80955821 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80904580-80924055 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80904580-80924055 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826259-80876968 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818019-80858302 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818019-80858302 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825992-80855137 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825992-80855137 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80810481-80862921 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80810481-80862921 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826421-80834902 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826104-80836440 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80819169-80854235 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826031-80855286 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826031-80855286 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825979-80838364 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807539-80877124 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807539-80877124 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80810474-80875047 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80810474-80875047 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80819315-80874900 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80819315-80874900 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826187-80864118 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826187-80864118 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826383-80834959 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826000-80835904 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80822630-80835396 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807606-80875630 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807606-80875630 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826040-80955811 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826040-80955811 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826040-80955811 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825976-80890850 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825976-80890850 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80787186-80924037 |
chr10:80792528 |
rs10824705 |
LOC283050 |
Red blood cell traits |
intron |
9.3e-08 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80793869 |
rs10762836 |
LOC283050 |
Coronary heart disease |
intron |
0.000528 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80795378 |
rs3910578 |
LOC283050 |
Coronary heart disease |
intron |
0.000292 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80797439 |
rs1946842 |
LOC283050 |
Red blood cell traits |
intron |
3.47e-07 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80797523 |
rs10824708 |
LOC283050 |
Coronary heart disease |
intron |
0.000239 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80797577 |
rs1946843 |
LOC283050 |
Coronary heart disease |
intron |
0.000241 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80797602 |
rs1946844 |
LOC283050 |
Coronary heart disease |
intron |
0.000304 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80798973 |
rs1439034 |
LOC283050 |
Coronary heart disease |
intron |
0.000239 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80800377 |
rs11002792 |
LOC283050 |
Autism spectrum disorders (language delay) |
intron |
9.45e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80787186-80924037 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80787186-80924037 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80818884-80871937 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818884-80871937 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826081-80888216 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826081-80888216 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826341-80844162 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826341-80844162 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826341-80844162 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826341-80844162 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826168-80955710 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826168-80955710 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826045-80873968 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-80873968 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818285-80854683 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818285-80854683 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818816-80955709 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80818816-80955709 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80818816-80955709 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825985-80877249 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825985-80877249 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826073-80957372 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826073-80957372 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826073-80957372 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826001-80877384 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826001-80877384 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825836-80955633 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825836-80955633 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825836-80955633 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825909-80957494 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825909-80957494 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825909-80957494 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825844-80963414 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825844-80963414 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825844-80963414 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807471-80877194 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807471-80877194 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807471-80877194 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80818930-80873968 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818930-80873968 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825985-80955812 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825985-80955812 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825985-80955812 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807554-80955616 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80807554-80955616 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80807554-80955616 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807554-80955616 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826000-80875606 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826000-80875606 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825823-81084066 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:80825823-81084066 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:80825823-81084066 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825823-81084066 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806797-80921022 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806797-80921022 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806797-80921022 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826025-80963378 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826025-80963378 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826025-80963378 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807212-80875547 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807212-80875547 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807212-80875547 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80818779-80877427 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818779-80877427 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826015-80957536 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826015-80957536 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826015-80957536 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825507-80875942 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825507-80875942 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825938-81009746 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825938-81009746 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825938-81009746 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818940-80871575 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818940-80871575 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80819230-80857903 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80819230-80857903 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818694-80856085 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818694-80856085 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826304-80955679 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826304-80955679 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826304-80955679 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826301-80956838 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826301-80956838 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826301-80956838 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826142-80887492 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826142-80887492 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807468-80865592 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807468-80865592 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807468-80865592 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826355-80920491 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826355-80920491 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826008-80846335 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826008-80846335 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826008-80846335 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826008-80846335 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826008-80846335 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826181-80845212 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826181-80845212 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826181-80845212 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826181-80845212 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826144-80854611 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80827018-80944199 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80827018-80944199 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80827018-80944199 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826527-80856172 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826527-80856172 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825795-80844183 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825795-80844183 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825795-80844183 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825795-80844183 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825895-80957054 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825895-80957054 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826477-80856345 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826477-80856345 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826233-80957401 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826233-80957401 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826233-80957401 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826025-80962471 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826025-80962471 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826025-80962471 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825168-80915851 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825168-80915851 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825998-80844227 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825998-80844227 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825998-80844227 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825998-80844227 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80827189-81003884 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80827189-81003884 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825646-80911719 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825646-80911719 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806212-80873549 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806212-80873549 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806212-80873549 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80808727-80862274 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80808727-80862274 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80808727-80862274 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80807512-80873154 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807512-80873154 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807512-80873154 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826284-80920969 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826284-80920969 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826270-80911808 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826270-80911808 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80805445-81048769 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80805445-81048769 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80805445-81048769 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80805445-81048769 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80805445-81048769 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826027-81037219 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80826027-81037219 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80826027-81037219 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826027-81037219 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806445-80965135 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80806445-80965135 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80806445-80965135 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806445-80965135 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826312-80925884 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826312-80925884 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826242-80889727 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826242-80889727 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826135-80846197 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826135-80846197 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826135-80846197 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826135-80846197 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826135-80846197 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826269-80846125 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826269-80846125 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826269-80846125 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826269-80846125 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826269-80846125 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826461-80844154 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826461-80844154 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826461-80844154 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826461-80844154 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826297-80845287 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826297-80845287 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826297-80845287 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826297-80845287 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80807700-81075191 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80807700-81075191 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80807700-81075191 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807700-81075191 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80811255-81047203 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80811255-81047203 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80811255-81047203 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80811255-81047203 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807555-80924379 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80807555-80924379 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80807555-80924379 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80826281-80862676 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826281-80862676 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825618-81047139 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825618-81047139 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825618-81047139 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825618-81047139 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825942-81047523 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825942-81047523 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80825942-81047523 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825942-81047523 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825920-81047562 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825920-81047562 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80825920-81047562 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825920-81047562 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826083-80920647 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826083-80920647 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825922-80965638 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825922-80965638 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825922-80965638 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825867-81059559 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80825867-81059559 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80825867-81059559 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825867-81059559 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806193-81085234 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81055626 |
rs12355688 |
ZMIZ1 |
Breast cancer |
intron |
6e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81057833 |
rs7905321 |
ZMIZ1 |
Response to alcohol consumption (flushing response) |
intron |
0.000573 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Cognitive test performance |
intron |
7.34e-05 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
9e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Asthma |
intron |
9e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease and Rheumatoid arthritis |
intron |
9.09e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Celiac disease |
intron |
8e-17 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Multiple sclerosis |
intron |
9.09e-10 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81058027 |
rs1250552 |
ZMIZ1 |
Osteoarthritis |
intron |
3.13e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81060005 |
rs4246943 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000321 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Inflammatory bowel disease (early onset) |
intron |
6e-09 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Crohn's disease |
intron |
1e-30 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81060317 |
rs1250550 |
ZMIZ1 |
Multiple sclerosis |
intron |
6e-09 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81076941 |
rs12784800 |
NA |
Liver disease in chronic hepatitis B virus infection |
NA |
3.71e-06 |
GWASdb |
| chr10:80806193-81085234 |
chr10:81082290 |
rs11002926 |
NA |
Suicide attempts in bipolar disorder |
NA |
0.000394 |
GWASdb |
| chr10:80806193-81085234 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80806193-81085234 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80806193-81085234 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80777724-80966619 |
chr10:80779004 |
rs16936718 |
LOC283050 |
Coronary heart disease |
intron |
0.000615 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80792528 |
rs10824705 |
LOC283050 |
Red blood cell traits |
intron |
9.3e-08 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80793869 |
rs10762836 |
LOC283050 |
Coronary heart disease |
intron |
0.000528 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80795378 |
rs3910578 |
LOC283050 |
Coronary heart disease |
intron |
0.000292 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80797439 |
rs1946842 |
LOC283050 |
Red blood cell traits |
intron |
3.47e-07 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80797523 |
rs10824708 |
LOC283050 |
Coronary heart disease |
intron |
0.000239 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80797577 |
rs1946843 |
LOC283050 |
Coronary heart disease |
intron |
0.000241 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80797602 |
rs1946844 |
LOC283050 |
Coronary heart disease |
intron |
0.000304 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80798973 |
rs1439034 |
LOC283050 |
Coronary heart disease |
intron |
0.000239 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80800377 |
rs11002792 |
LOC283050 |
Autism spectrum disorders (language delay) |
intron |
9.45e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80813333 |
rs10762840 |
LOC283050 |
Urinary metabolites |
intron |
2e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80777724-80966619 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80777724-80966619 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80777724-80966619 |
chr10:80808928 |
rs10882097 |
FARSBP1 - WARS2P1 |
Exploratory eye movement dysfunction in schizophrenia (cognitive search score) |
intergenic_variant |
2e-06 |
GWAS_Catalog |
| chr10:80825176-81047254 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80825176-81047254 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80825176-81047254 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825176-81047254 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826288-80964712 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826288-80964712 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826288-80964712 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818339-80871937 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818339-80871937 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818336-80872265 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818336-80872265 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80815350-80871292 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80815350-80871292 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826330-80913132 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826330-80913132 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826079-80912868 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826079-80912868 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826408-80854894 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826408-80854894 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826264-80912619 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826264-80912619 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826451-80855380 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826451-80855380 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826076-81010378 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80826076-81010378 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826076-81010378 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826445-80915837 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826445-80915837 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80822927-80920412 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80822927-80920412 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826447-80911540 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826447-80911540 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80825951-80957344 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80825951-80957344 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80825951-80957344 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818083-81036401 |
chr10:80818256 |
rs946719 |
LOC283050 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80818083-81036401 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80818083-81036401 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80818083-81036401 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80818430-81004233 |
chr10:80819132 |
rs704017 |
LOC283050 |
Colorectal cancer |
intron |
2e-08 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80818430-81004233 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80818430-81004233 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826166-80866296 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826166-80866296 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826341-80923635 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826341-80923635 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826301-80923770 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826301-80923770 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826045-81047534 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80916381 |
rs780153 |
ZMIZ1 |
Urinary metabolites |
intron |
7.6e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80918572 |
rs779932 |
ZMIZ1 |
Urinary metabolites |
intron |
1.5e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000143 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80919442 |
rs749821 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80920370 |
rs4980038 |
ZMIZ1 |
fMRI brain tests in schizophrenia |
intron |
0.000436 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80921864 |
rs697241 |
ZMIZ1 |
Urinary metabolites |
UTR-5 |
1.9e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
End-stage renal disease |
intron |
8.1e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Meningococcal disease |
intron |
6.5e-13 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80923862 |
rs1749824 |
ZMIZ1 |
Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) |
intron |
8.91e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80925577 |
rs7916441 |
ZMIZ1 |
Height |
intron |
6e-10 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80927651 |
rs703992 |
ZMIZ1 |
Urinary metabolites |
intron |
7e-07 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80928793 |
rs1815314 |
ZMIZ1 |
Urinary metabolites |
intron |
2.2e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80929130 |
rs703991 |
ZMIZ1 |
Urinary metabolites |
intron |
1.8e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000874 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80931240 |
rs703989 |
ZMIZ1 |
Urinary metabolites |
intron |
3.4e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Height |
intron |
2e-09 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80931481 |
rs780151 |
ZMIZ1 |
Weight |
intron |
3.86e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.16e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80932607 |
rs10824726 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
8.35e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80934948 |
rs780149 |
ZMIZ1 |
Multiple complex diseases |
intron |
9e-04 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Multiple complex diseases |
intron |
5.67e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80935083 |
rs780148 |
ZMIZ1 |
Bipolar disorder |
intron |
4.66e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942620 |
rs810517 |
ZMIZ1 |
Multiple complex diseases |
intron |
1.79e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (males) |
intron |
6.4e-07 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes (females) |
intron |
1.2e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
1e-10 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942631 |
rs12571751 |
ZMIZ1 |
Type 2 diabetes |
intron |
2e-10 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80942721 |
rs703982 |
ZMIZ1 |
Multiple complex diseases |
intron |
2.72e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000127 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
1.68e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000215 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80944095 |
rs703979 |
ZMIZ1 |
Osteoarthritis (knee and hip) |
intron |
0.000392 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80952826 |
rs703972 |
ZMIZ1 |
Attention deficit hyperactivity disorder |
intron |
0.000172 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80953136 |
rs703970 |
ZMIZ1 |
Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) |
intron |
5e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80953393 |
rs703969 |
ZMIZ1 |
Serum metabolites |
intron |
6.09e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80955067 |
rs703965 |
ZMIZ1 |
Bipolar disorder |
intron |
8e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80959973 |
rs10128264 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80960828 |
rs2802369 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
7e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80962411 |
rs2490275 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000153 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80965109 |
rs942794 |
ZMIZ1 |
Response to methotrexate in juvenile idiopathic arthritis |
intron |
1.06e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80966678 |
rs745417 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000197 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80983786 |
rs1250590 |
ZMIZ1 |
Hypertension (early onset hypertension) |
intron |
0.000641686 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80986678 |
rs1250592 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000585 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81011589 |
rs11002892 |
ZMIZ1 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
3.5e-05 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81015896 |
rs11593576 |
ZMIZ1 |
Vitiligo |
intron |
8e-07 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Inflammatory bowel disease |
intron |
3e-18 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81032532 |
rs1250546 |
ZMIZ1 |
Psoriasis |
intron |
6.8e-07 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81032885 |
rs1250544 |
ZMIZ1 |
Crohn's disease and psoriasis |
intron |
7e-14 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81034670 |
rs1250542 |
ZMIZ1 |
Multiple sclerosis |
intron |
4e-07 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81034913 |
rs1250541 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000107 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
2e-06 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81036007 |
rs1250540 |
ZMIZ1 |
Multiple sclerosis |
intron |
0.00039 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81037800 |
rs1250538 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000132 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81043707 |
rs1892497 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000542 |
GWASdb |
| chr10:80826045-81047534 |
chr10:81047342 |
rs1250564 |
ZMIZ1 |
Multiple complex diseases |
intron |
0.000225 |
GWASdb |
| chr10:80826045-81047534 |
chr10:80939735 |
rs1484170 |
FARSBP1 - WARS2P1 |
Cardiac hypertrophy |
downstream_gene_variant |
1e-06 |
GWAS_Catalog |
| chr10:80826045-81047534 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826153-80891156 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826153-80891156 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826032-80890839 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826032-80890839 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826077-80890519 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826077-80890519 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826325-80890832 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Breast cancer |
intron |
3.4e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80857533 |
rs11002813 |
ZMIZ1 |
Smoking cessation |
intron |
0.000676 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80858473 |
rs11002814 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80858592 |
rs11002816 |
ZMIZ1 |
Breast cancer |
intron |
3.3e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80872483 |
rs11002824 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80873443 |
rs16936863 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80873608 |
rs17557872 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80873883 |
rs11002825 |
ZMIZ1 |
Breast cancer |
intron |
4e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80874092 |
rs11002826 |
ZMIZ1 |
Breast cancer |
intron |
3.9e-06 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80878219 |
rs4336976 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000418 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80880435 |
rs11002832 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.00051 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80880900 |
rs11002835 |
ZMIZ1 |
Type 2 diabetes |
intron |
0.000778 |
GWASdb |
| chr10:80826325-80890832 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |
| chr10:80826222-80856088 |
chr10:80834685 |
rs4980022 |
ZMIZ1 |
Smoking initiation |
intron |
0.000495 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
4e-09 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80841148 |
rs704010 |
ZMIZ1 |
Breast cancer |
intron |
7e-22 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80843548 |
rs4980027 |
ZMIZ1 |
Response to TNF antagonist treatment |
intron |
0.000751 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80845411 |
rs1250009 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80846608 |
rs1250005 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80846814 |
rs1250003 |
ZMIZ1 |
Breast cancer |
intron |
1.6e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80849336 |
rs1250000 |
ZMIZ1 |
Breast cancer |
intron |
1.8e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80851257 |
rs719338 |
ZMIZ1 |
Breast cancer |
intron |
2.1e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80852602 |
rs873823 |
ZMIZ1 |
Breast cancer |
intron |
4.4e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80853508 |
rs1250013 |
ZMIZ1 |
Amyotrophic lateral sclerosis (sporadic) |
intron |
0.000356 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80855423 |
rs10762844 |
ZMIZ1 |
Breast cancer |
intron |
8.5e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80855650 |
rs11002811 |
ZMIZ1 |
Breast cancer |
intron |
2.6e-06 |
GWASdb |
| chr10:80826222-80856088 |
chr10:80853186 |
|
|
Cobalt levels |
|
7e-06 |
GWAS_Catalog |